Lasdul

Duloxetine, the active ingredient in Lasdul, is a serotonin‑norepinephrine reuptake inhibitor (SNRI) presented as an oral tablet for oral use. It is prescribed for several chronic pain and mood disorders in adult patients.

GNH USA supplies Lasdul as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Duloxetine acts on serotonin and norepinephrine pathways and is indicated for several psychiatric and pain conditions. - Major depressive disorder: reduces depressive symptoms and improves overall mood. - Generalized anxiety disorder: alleviates excessive worry and anxiety. - Diabetic peripheral neuropathic pain: lessens nerve‑related pain in diabetic patients. - Fibromyalgia: decreases widespread musculoskeletal pain and fatigue. - Chronic musculoskeletal pain: provides relief from persistent musculoskeletal discomfort.

Duloxetine may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: transient stomach upset, often early in therapy. - Dry mouth: reduced salivation causing discomfort. - Dizziness: light‑headed sensation, especially when standing quickly. - Somnolence: increased sleepiness or fatigue.

Serious or Rare Side Effects: - Suicidal thoughts: emergence of suicidal ideation, particularly in young adults. - Serotonin syndrome: potentially life‑threatening condition with agitation, hyperthermia, and muscle rigidity. - Severe liver injury: jaundice, dark urine, or elevated liver enzymes. - Hyponatremia: low blood sodium causing confusion or seizures. - Severe allergic reaction: rash, swelling, or difficulty breathing.

Before initiating therapy, clinicians should evaluate specific risk factors and monitor patients closely. - Assess for suicidal ideation: monitor mood changes, especially during the first weeks. - Evaluate liver function: avoid use in patients with significant hepatic impairment. - Review concomitant serotonergic agents: increase risk of serotonin syndrome. - Monitor blood pressure: duloxetine may cause modest elevations. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture and direct sunlight.

Duloxetine can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis and serotonin syndrome. - Serotonergic antidepressants (e.g., SSRIs, tricyclics): heightened serotonin toxicity. - Strong CYP1A2 inhibitors (e.g., fluvoxamine): may increase duloxetine plasma levels.

Moderate Interactions (Monitor Closely): - CYP2D6 substrates (e.g., codeine, tamoxifen): duloxetine may reduce their effectiveness. - Anticoagulants (e.g., warfarin): potential for increased bleeding risk. - NSAIDs or antiplatelet agents: may augment gastrointestinal bleeding risk.